Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$4.72
Net Income/Share$1.77
Operating CF/Share$1.91
Free CF/Share$1.91
Cash/Share$5.63
Book Value/Share$7.51
Tangible Book/Share$6.46
Equity/Share$7.51
Interest Debt/Share$0.02
CapEx/Share$0.00
Dividend/Share$0.00
Valuation
Market Cap$3.06B
Enterprise Value$2.38B
P/E Ratio14.05P/S Ratio5.30P/OCF Ratio13.02
P/FCF Ratio13.06
P/B Ratio3.32P/TB Ratio3.32
EV/Sales4.11EV/EBITDA7.81
Graham Valuation
Graham Number$17.31
Graham Net-Net$5.32
Profitability
Earnings Yield7.12%FCF Yield7.66%ROE26.39%ROIC21.34%Return on Tangible Assets23.57%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF0.05%
CapEx/Revenue0.02%
CapEx/Depreciation0.00
SBC/Revenue4.20%
SG&A/Revenue25.02%
R&D/Revenue2.54%
Liquidity & Solvency
Debt/Equity0.00Debt/Assets0.00Debt/Market Cap0.00
Net Debt/EBITDA-2.26
Current Ratio6.62Interest Coverage0.00xIncome Quality1.08Efficiency
Days Sales Outstanding67 days
Days Payables Outstanding35 days
Days Inventory108 days
Receivables Turnover5.42x
Payables Turnover10.42x
Inventory Turnover3.38x
Capital Structure
Tangible Assets$791.61M
Working Capital$723.72M
Invested Capital$855.44M
Intangibles/Assets12.23%